RSS Feed For (NY:MED)

MEDIFAST, Inc. (NY:MED)

26.69 0.6 (2.2%)
MEDIFAST, Inc. (NY:MED) Delayed :
Previous Close $27.29    52 Week High $28.67 
Open $26.87    52 Week Low $3.35 
Day High $27.06    P/E 40.44 
Day Low $26.19    EPS $0.66 
Volume 584,380       
More MED Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
GERN 3 AET 2
HAR 2 S 2
AET 2 NM 2
HAR 2 GERN 2
NM 2 GTIV 2
MTG 2 TVL 2
View All Friends, Peers and Foes

View All Major News StreetInsider.com Major News for MED

Oct 29, 2009 07:25 AM Medifast (MED) Reports Q3 EPS of $0.23, Beats by 4c
Jul 30, 2009 09:30 AM Medifast (MED) Tops Q2 View By 3c
Apr 29, 2009 08:06 AM Medifast (MED) Tops Q1 View 5c
View All Major News

StreetInsider Reports on MED by Category

Comments on recent MED articles

Greg Rex
on Sep 11, 2009
at 02:01 PM
Medifast Stock at $19 The TSFL Multi-Level marketing will not win the day on YOY growth rates Medifast sports with a 40 PE at $19 a share. Major dilution underway. Medifast stock is risky speculation.
Article: Stocklemon.com issue negative report on Medifast (MED)
CivilServing
on Jun 10, 2009
at 02:16 PM
MED DownGrade Medifast (NYSE – MED) downgraded due to insider trades, poor Auditor transparency/conflicts and potential risk that their recent Revenue reporting may be revised down. .This is going to get much worse before it gets better –going down to $5.00 So the Chairman’s household sold a cool Million dollars worth of the stock in the last round – Each share sold under the knowledge of an investigation into MED and its revenue recognition categories. “Brad” has been out posting again, a disclosure and dissemination of inside information in violation of SEC rules prohibiting such “insider” communications. (Whole Foods CEO ring a bell?) Minkow is not going away and appears to have made real headway with the Auditor conflict – (Selling shares or not – owning a brokerage house is the real conflict) I am asking here – does anyone know of an auditor of publicly traded companies, who also owns a Brokerage company too? I can’t find one at all! MED’s miraculous revenue increase last Q, - was mandatory to get MED off the NYSE’s dreaded “Watch List”. This revenue recognition was masterminded by the Chairman and the conflicted Auditor – it may have to be revised…. (What is the NYSE’s internal control doing about this too?)
Article: Medifast (MED) Chairman's Wife Cashes In Over $1M In Stock

Comments on MED


No comments are currently available.